Is it safe to give anthracyclines concurrently with trastuzumab in neo-adjuvant or metastatic settings for HER2-positive breast cancer? A meta-analysis of randomized controlled trials
Crossref DOI link: https://doi.org/10.1007/s12032-014-0340-x
Published Online: 2014-11-22
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Du, Feng
Yuan, Peng
Zhu, Wenjie
Wang, Jiayu
Ma, Fei
Fan, Ying
Xu, Binghe
Text and Data Mining valid from 2014-11-22